NCT04718922View on ClinicalTrials.gov

Chlorhexidine Mouthrinse Before EBUS-TBNA

PHASE4CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

January 20, 2021

Primary Completion Date

June 11, 2021

Study Completion Date

December 11, 2021

Conditions
Endobronchial Ultrasound
Interventions
DRUG

Chlorhexidine Gluconate 0.12 % Mouthwash

Intervention with chlorhexidine mouthrinse will be performed approximately 10 min before the start of EBUS-TBNA

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT04718922 - Chlorhexidine Mouthrinse Before EBUS-TBNA | Biotech Hunter | Biotech Hunter